A carregar...
Viral hepatitis screening guideline before biological drug use in rheumatic patients
Biological drugs (tumor necrosis factor inhibitors, rituximab, tocilizumab, abatacept, and tofacitinib) are important treatment alternatives in rheumatology, particularly for resistant patients. However, they may cause hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivation; for instance, H...
Na minha lista:
| Publicado no: | Eur J Rheumatol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medical Research and Education Association
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042270/ https://ncbi.nlm.nih.gov/pubmed/27708965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.150072 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|